The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dacarbazine medac 200 mg, powder for solution for injection/infusion

200 milligram(s) Powder for solution for injection/infusion

medac Gesellschaft für klinische Spezialpräparate mbHPA0623/003/002

Main Information

Trade NameDacarbazine medac 200 mg, powder for solution for injection/infusion
Active SubstancesDacarbazine
Strength200 milligram(s)
Dosage FormPowder for solution for injection/infusion
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberPA0623/003/002

Group Information

ATC CodeL01AX Other alkylating agents
L01AX04 dacarbazine


Licence Issued14/11/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back